Heart patients face dilemma: aspirin or not before colonoscopy?

NCT ID NCT07052799

Recruiting now Disease control Sponsor: Chinese University of Hong Kong Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether people at moderate risk for heart problems should continue or stop taking aspirin before a colonoscopy. About 2,500 participants will be randomly assigned to take either aspirin or a placebo for a few days around the procedure. The goal is to see which approach leads to fewer heart attacks or serious bleeding.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Aspirin 80mg
What this could lead to: If it works, this could provide clear guidance on whether to continue or stop aspirin before colonoscopy, reducing heart attacks or bleeding risks.
What could go wrong: This is a single trial, and results may not apply to all patients. The differences between strategies may be small and not conclusive.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cardiovascular disorder myocardial infarction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARDIOVASCULAR EVENTS MYOCARDIAL INFARCTION (MI) POST POLYPECTOMY BLEEDING IN ANTIPLATELET PATIENTS

Heart patients face dilemma: aspirin or not before colonoscopy?

Summary

What this could mean

Get notified about this study

Conditions

As listed by the trial registrant

Contacts and locations

Locations

More trials for these conditions